Highlights,The GLP-1 market for obesity and diabetes treatments is gaining momentum, with Novo Nordisk and Eli Lilly leading ...

Emma Williams (right), 23, from Wrexham, Wales, bought the slimming jabs - which contained semaglutide, the same active ...

Highlights,Significant Prescription Increases,: Citi reports a 244% rise in prescriptions for obesity drugs and an 18% ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Wegovy – the brand name for semaglutide, the same compound that is in Ozempic – was launched for weight loss in the US in 2021 and quickly became so popular that the manufacturer, Novo Nordisk, could ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

One creator suggests that lemon balm helps with stress, insomnia, alertness, and that it’s been found to potentially help ...

Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

The Center for Human Nutrition at the U of A is conducting a research study to learn more about the effects of protein on ...